Beth Faiman expresses her excitement about the newly approved multiple myeloma treatments but believes that they will also bring about new challenges.
I am thrilled that all these new drugs have been approved in 2015. We have three new drugs within the last 10 days. I cannot underscore the importance of this is for our patients and the clinicians.
This will provide a whole host of new challenges, however, with educating the nurses, and how to get the drugs, educating the patients as to how to take the drugs, and getting the drugs to the patients. Meaning, if I write a prescription, how hard is it for them to actually get that prescription filled.